Reading AMP? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track AMP free→Reading AMP? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track AMP free→QuarterlyIQ Insights · AMP
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Other Events. On June 9, 2026, Ameriprise Financial, Inc. (the “Company”) issued $300,000,000 aggregate principal amount of its 4.800% Senior Notes due 2031 (the “2031 Notes”) and $450,000,000 aggregate principal amount of its 5.350% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes, the “Notes”). The Notes were sold pursuant to the Underwriting Agreement (the “Underwriting Agreement”) that the Company entered into on June 4, 2026 with BofA Securities, Inc., Citigroup…
Results of Operations and Financial Condition. Ameriprise Financial, Inc. furnishes herewith, on Exhibit 99.1, a press release issued April 23, 2026 announcing its financial results for the first quarter of 2026.
Results of Operations and Financial Condition. Ameriprise Financial, Inc. furnishes herewith, on Exhibit 99.1, a press release issued January 29, 2026 announcing its financial results for the fourth quarter of 2025.
Results of Operations and Financial Condition. Ameriprise Financial, Inc. furnishes herewith, on Exhibit 99.1, a press release issued October 30, 2025 announcing its financial results for the third quarter of 2025.
Results of Operations and Financial Condition. Ameriprise Financial, Inc. furnishes herewith, on Exhibit 99.1, a press release issued July 24, 2025 announcing its financial results for the second quarter of 2025.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.